The two Covid-19 vaccines given approval for restricted use would not be available in the open market. It will have to wait till the country’s apex drug regulator, DCGI, approves the data sought from the manufacturers. No market authorisation has been given to any of the emergency-approved vaccines currently in use in India and abroad. Market authorisation is a prerequisite to sell vaccines in the open market. Vaccine manufacturers had committed on timelines to submit data, which would be assessed by the regulator. The final data from the vaccines’ phase-three clinical trials should be scrutinised before their full pre-qualification.